Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 932

2'-fucosyllactose

Intended Use: Intended for use as an ingredient at a level of 2.4 g/L of formula as consumed in milk- and soy-based, non-exempt infant formula for term infants; at a level of 2.4 g/L in drinks for toddlers and children ages 1-3 years, as consumed; at levels ranging from 0.24-1.2 g/serving in infant and toddler foods; and at levels ranging from 0.28-1.2 g/serving in beverage and beverages bases, breakfast cereals, dairy product analogs, frozen dairy desserts and mixes, gelatins, puddings, fillings, grain products and pastas, jams and jellies, milk and milk products, processed fruits and fruit juices, and sweet sauces, toppings and syrup.
Basis: Scientific procedures
Notifier: Advanced Protein Technologies Corp.
Notifier Address: 59-5 Seogeunnae-gil
Paltan-myeon, Hwasung City
Gyeonggi-do, 18575
REPUBLIC OF KOREA
GRAS Notice (releasable information): GRN 932 (in PDF) (3.2 MB)
  Part 2: GRN 932 amendments (3.6 MB)
Date of closure: Feb 18, 2021
FDA's Letter: FDA has no questions (in PDF) (223 kB)
-
-